Table 2.
Treatment (n) | D1R-tmtmice | D1-MSNs analyzed | D2R-eGFP mice | D2-MSNs analyzed |
---|---|---|---|---|
Sham-lesioned (18) | 8 | 9 | 10 | 10 |
Parkinsonian (18) | 10 | 12 | 8 | 12 |
Dyskinetic (23) | 11 | 12 | 12 | 14 |
Treatment (n) | D1R-tmtmice | D1-MSNs analyzed | D2R-eGFP mice | D2-MSNs analyzed |
---|---|---|---|---|
Sham-lesioned (18) | 8 | 9 | 10 | 10 |
Parkinsonian (18) | 10 | 12 | 8 | 12 |
Dyskinetic (23) | 11 | 12 | 12 | 14 |